Published by Abigail Townsend on 23rd July 2026
(Sharecast News) - A breast cancer drug developed by AstraZeneca has been approved in the European Union for the treatment of certain types of the disease, the pharmaceutical giant announced on Thursday.
URL: http://www.digitallook.com/dl/news/story/36091890/...